Clinical Rheumatology

, Volume 26, Issue 3, pp 376–379 | Cite as

QT dispersion increases in patients with systemic lupus erythematosus

  • Bunyamin Yavuz
  • Enver Atalar
  • Omer Karadag
  • Erol Tulumen
  • Necla Ozer
  • Ali Akdogan
  • Ihsan Ertenli
  • Sedat Kiraz
  • Meral Calguneri
  • Ferhan Ozmen
Original Article

Abstract

Although autopsy studies have documented that heart is affected in most of systemic lupus erythematosus (SLE) patients, clinical manifestations occur in less than 10%. QT dispersion, a new parameter that can be used to assess homogeneity of cardiac repolarization and autonomic function, has not been studied in SLE patients. The aim of our study was to evaluate the QT dispersion (QTd) in SLE patients without overt cardiac involvement. Eighty-three patients with a diagnosis of SLE (mean age 41±13) and age- and sex-matched 77 healthy control subjects (mean age 43±10) were enrolled in the study. All subjects had their complete history taken, laboratory examination, and transthoracic echocardiography (ECG). Patients with cardiac disease, hypertension, diabetes, or taking medications that may effect QTd or any ECG abnormalities were excluded. Resting 12-lead ECG were recorded for measurement of QTd. None of the patients and control subjects had overt cardiac involvement. The mean SLE duration was 86.5±15.4 months. QT dispersion was significantly greater in SLE patients than incontrol subjects (55.2±24.7 vs 20.7±5.3 ms, respectively; p<0.001). There was no correlation between QTd and duration of SLE, SLEDAI-K score, corticosteroid usage, and presence of anti SS-A antibody. QT dispersion is significantly increased in SLE patients without overt cardiac involvement. Our result suggests that prolonged QT dispersion can be a useful noninvasive and simple method for early detection of cardiac involvement in SLE patients.

Keywords

Autoimmune disease Cardiac involvement Electrocardiography QT dispersion Systemic lupus erythematosus Ventricular repolarization 

References

  1. 1.
    Mandell BF (1987) Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 17:126–141PubMedCrossRefGoogle Scholar
  2. 2.
    Hejtmancik MR, Wright JC, Quint R, Jennings FL (1964) The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 68:119–130PubMedCrossRefGoogle Scholar
  3. 3.
    Kautzner J, Malik M (1997) QT interval dispersion and its clinical utility. PACE 20:2625–2640PubMedGoogle Scholar
  4. 4.
    Zabel M, Portnoy S, Franz MR (1995) Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 25:746PubMedCrossRefGoogle Scholar
  5. 5.
    Yildirir A, Aksoyek S, Calguneri M et al (2000) QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis. Rheumatology (Oxford) 39(8):875–879CrossRefGoogle Scholar
  6. 6.
    Pırıldar T, Sekuri C, Utuk O, Kemal Tezcan U (2003) QT dispersion in rheumatoid arthritis patients with and without Sjögren’s syndrome. Clin Rheumatol 22:225–228PubMedCrossRefGoogle Scholar
  7. 7.
    Cindas A, Gokce-Kutsal Y, Tokgozoglu L, Karanfil A (2002) QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol 31(1):22–26PubMedCrossRefGoogle Scholar
  8. 8.
    Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedGoogle Scholar
  9. 9.
    Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291PubMedGoogle Scholar
  10. 10.
    Marek M, Camm AJ (1997) Mystery of QTc interval dispersion. Am J Cardiol 79:785–787CrossRefGoogle Scholar
  11. 11.
    Zabel M, Woosly RL, Franz MR (1997) Is dispersion of ventricular repolarisation rate dependent? PACE 20(Part I):2405–2411PubMedGoogle Scholar
  12. 12.
    Perkiomaki JS, Koistien J, Yli-Mary S, Huikuri HV (1995) Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarhythmias after previous myocardial infarction. J Am Coll Cardiol 26:174–179PubMedCrossRefGoogle Scholar
  13. 13.
    Statters DJ, Malik M,Ward DE, Camm AJ (1994) QT dispersion: problems of methodology and clinical significance. J Cardiovasc Electrophysiol 5:672–685PubMedGoogle Scholar
  14. 14.
    Glancy JM, Garratt CJ, Woods KI, de Bono DP (1995) QT dispersion and mortality after myocardial infarction. Lancet 345:945–948PubMedCrossRefGoogle Scholar
  15. 15.
    Tieleman RG, Crijns HJ, Wiesfeld AC, Posma J, Hamer HM, Lie KI (1995) Increased dispersion of recractoriness in the absence of QT prolongation in patients with mitral valve prolapse and ventricular arrhythmias. Br Heart J 73:37–40PubMedGoogle Scholar
  16. 16.
    Barr CS, Naas A, Freeman M, Lang CC, Struthers AD (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343:327–329PubMedCrossRefGoogle Scholar
  17. 17.
    Sgreccia A, Morelli S, Ferrante L et al (1998) QT interval and QT dispersion in systemic sclerosis (scleroderma). J Int Med 243:127–132Google Scholar
  18. 18.
    Schillaci O, Lagana B, Danieli R et al (1999) Technetium-99 m sestamibi single-photon emission tomography detects subclinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus. Eur J Nucl Med 26(7):713–717PubMedCrossRefGoogle Scholar
  19. 19.
    Lin CC, Ding HJ, Chen YW, Wang JJ, Ho ST, Kao A (2003) Usefulness of technetium-99 m sestamibi myocardial perfusion SPECT in detection of cardiovascular involvement in patients with systemic lupus erythematosus or systemic sclerosis. Int J Cardiol 92:157–161PubMedCrossRefGoogle Scholar
  20. 20.
    Sun SS, Shiau YC, Tsai SC, Lin CC, Kao A, Lee CC (2001) The role of technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erythematosus patients with non-specific chest complaints. Rheumatology 40:1106–1111CrossRefGoogle Scholar
  21. 21.
    Lagana B, Tubani L, Maffeo N et al (1996) Heart rate variability and cardiac autonomic function in systemic lupus erythematosus. Lupus 1:49–55Google Scholar
  22. 22.
    Wei K, Dorian P, Newman D, Langer A (1995) Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. J Am Coll Cardiol 26:859–863PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2006

Authors and Affiliations

  • Bunyamin Yavuz
    • 1
  • Enver Atalar
    • 1
  • Omer Karadag
    • 2
  • Erol Tulumen
    • 1
  • Necla Ozer
    • 1
  • Ali Akdogan
    • 2
  • Ihsan Ertenli
    • 2
  • Sedat Kiraz
    • 2
  • Meral Calguneri
    • 2
  • Ferhan Ozmen
    • 1
  1. 1.Department of Cardiology, Faculty of MedicineHacettepe UniversityAnkaraTurkey
  2. 2.Division of Rheumatology, Department of Internal Medicine, Faculty of MedicineHacettepe UniversityAnkaraTurkey

Personalised recommendations